Response to Trametinib of a Pulmonary Langerhans Cell Histiocytosis Harboring a MAP2K1 Deletion

被引：26
|
作者：
Lorillon, Gwenael [1 ]
Jouenne, Fanelie [1 ,2 ]
Baroudjian, Barouyr [1 ]
de Margerie-Mellon, Constance [1 ,2 ]
Vercellino, Laetitia [1 ]
Meignin, Veronique [1 ,3 ]
Lebbe, Celeste [1 ,2 ,4 ]
Vassallo, Robert [5 ]
Mourah, Samia [1 ,2 ,4 ]
Tazi, Abdellatif [1 ,2 ,6 ]
机构：
[1] AP HP, Paris, France
[2] Univ Paris Diderot, Paris, France
[3] INSERM, UMR S1165, Paris, France
[4] INSERM, U976, Paris, France
[5] Mayo Clin, Rochester, MN USA
[6] CRESS, U1153, Paris, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 198卷 / 05期
关键词：
ERDHEIM-CHESTER DISEASE; MUTATIONS; VEMURAFENIB; ACTIVATION;
D O I：
10.1164/rccm.201802-0275LE
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：675 / 678
页数：4
相关论文
共 50 条
  • [31] Trametinib-Induced Remission of an MEK1-Mutated Langerhans Cell Histiocytosis
    Papapanagiotou, Matina
    Griewank, Klaus G.
    Hillen, Uwe
    Schimming, Tobias T.
    Moeller, Lars C.
    Fuehrer, Dagmar
    Zimmer, Lisa
    Roesch, Alexander
    Sucker, Antje
    Schadendorf, Dirk
    Livingstone, Elisabeth
    Schilling, Bastian
    JCO PRECISION ONCOLOGY, 2017, 1
  • [32] Ganglioglioma with MAP2K1 Mutation and CDKN2A/B Homozygous Deletion: A Case Report
    Zhao, Chi
    Li, Cheng
    Ge, Jing-Jing
    Zhang, Jun-Ping
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (10)
  • [33] HETEROGENITY OF HISTIOCYTOSES WITH MAP2K1 MUTATIONS
    Emile, Jean-Francois
    Helias-Rodzewica, Zofia
    Heritier, Sebastien
    Terrones, Nathalie
    Kotokpo-Youkou, Gaella
    Cohen-Aubart, Fleur
    Donadieu, Jean
    Haroche, Julien
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S13 - S13
  • [34] Cutaneous Rosai Dorfman disease harboring RET and MAP2K1 mutations, successfully treated with methotrexate
    Konstantinou, Maria P.
    Tournier, Emilie
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (11) : 1409 - 1411
  • [35] BRAFV600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell-like histiocytosis in immune-deficient mice
    Rafiei, Anahita
    Wilk, C. Matthias
    Helbling, Patrick M.
    Myburgh, Renier
    Saito, Yasuyuki
    Haralambieva, Eugenia
    Soldini, Davide
    Chakraborty, Rikhia
    Merad, Miriam
    Allen, Carl E.
    Nombela-Arrieta, Cesar
    Manz, Markus G.
    BLOOD ADVANCES, 2020, 4 (19) : 4912 - 4917
  • [36] A recurrent neuroepithelial tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion
    Karlovich, E.
    Sun, Y.
    Canoll, P.
    Fecher, R.
    Welch, M.
    McKhann, G.
    Goldman, J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 506 - 506
  • [37] Co-occurrence of targetable aberrations in non-small cell lung cancer patients harboring MAP2K1 mutations
    Holzem, A.
    Nogova, L.
    Ihle, M. A.
    Woempner, C.
    Bitter, E.
    Michels, S.
    Fischer, R. N.
    Kron, A.
    Gerigk, U.
    Kern, J.
    Kaminsky, B.
    Randerath, W. J.
    Lorenz, J.
    Kambartel, K.
    Merkelbach-Bruse, S.
    Buttner, R.
    Scheffler, M.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 250 - 250
  • [38] Histiocytic Neoplasm Harboring a MAP2K1 Gene Mutation Presenting as a Dural Mass. A Case Presentation
    Castro, Diana
    Diamond, Eli
    Moung, Christine
    Rosenblum, Marc
    Liu, James
    Baisre, Ada
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (06): : 524 - 524
  • [39] Pulmonary Langerhans cell histiocytosis (histiocytosis X) on bronchoalveolar lavage - A report of 2 cases
    Zeppa, Pio
    Cozzolino, Immacolata
    Russo, Maria
    Cataldo, Pietro Tullio
    Vetrani, Antonio
    Palombini, Lucio
    ACTA CYTOLOGICA, 2007, 51 (03) : 480 - 482
  • [40] Response to MEK Inhibitor Therapy in MAP2K1 (MEK1) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer
    Cheng, Michael L.
    Lee, Jessica K.
    Kumar, Rachit
    Klein, Harry
    Raskina, Kira
    Schrock, Alexa B.
    Michael, Kesi S.
    Mazor, Tali
    Cerami, Ethan
    Oxnard, Geoffrey R.
    Liu, David
    Beltran, Himisha
    Sholl, Lynette M.
    Nishino, Mizuki
    Janne, Pasi A.
    JCO PRECISION ONCOLOGY, 2022, 6
12345